These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24610309)

  • 41. Triple versus dual antiplatelet therapy after percutaneous coronary intervention for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II Registry.
    Song PS; Song YB; Yang JH; Hahn JY; Choi SH; Choi JH; Lee SH; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    Heart Vessels; 2015 Jul; 30(4):458-68. PubMed ID: 24682436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term (10-year) outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease.
    Park S; Ahn JM; Lee K; Kwon O; Park H; Yoon YH; Kang DY; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    Am Heart J; 2019 Dec; 218():9-19. PubMed ID: 31655415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
    Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
    JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries.
    Choo EH; Chang K; Lee KY; Lee D; Kim JG; Ahn Y; Kim YJ; Chae SC; Cho MC; Kim CJ; Kim HS; Jeong MH;
    J Am Heart Assoc; 2019 Jul; 8(14):e011990. PubMed ID: 31284804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Watanabe H; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Tazaki J; Watanabe H; Natsuaki M; Minatoya K; Hanyu M; Komiya T; Kimura T;
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):42-51. PubMed ID: 31389659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Lewis BS; Murphy SA; McCabe CH; Braunwald E;
    JAMA; 2005 Sep; 294(10):1224-32. PubMed ID: 16143698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ; Kibiro M; Eichhöfer J; Curzen NP
    Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex differences in the treatment and outcome of patients with acute coronary syndrome after percutaneous coronary intervention: a population-based study.
    Lin CF; Shen LJ; Hsiao FY; Gau CS; Wu FL
    J Womens Health (Larchmt); 2014 Mar; 23(3):238-45. PubMed ID: 24286239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preferred Revascularization Strategies in Patients with Ischemic Heart Failure: A Meta-Analysis.
    Xiao J; Xu F; Yang CL; Chen WQ; Chen X; Zhang H; Wei ZJ; Liu JP
    Curr Med Sci; 2018 Oct; 38(5):776-784. PubMed ID: 30341512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative Outcomes.
    Kurlansky P; Herbert M; Prince S; Mack M
    Circulation; 2016 Oct; 134(17):1238-1246. PubMed ID: 27777293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
    Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES
    J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
    Steinhubl SR; Berger PB; Mann JT; Fry ET; DeLago A; Wilmer C; Topol EJ;
    JAMA; 2002 Nov; 288(19):2411-20. PubMed ID: 12435254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
    Vaduganathan M; Harrington RA; Stone GW; Deliargyris EN; Steg PG; Gibson CM; Hamm CW; Price MJ; Menozzi A; Prats J; Elkin S; Mahaffey KW; White HD; Bhatt DL;
    J Am Coll Cardiol; 2017 Jan; 69(2):176-185. PubMed ID: 28081827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Ebrahimi R; Dyke C; Mehran R; Manoukian SV; Feit F; Cox DA; Gersh BJ; Ohman EM; White HD; Moses JW; Ware JH; Lincoff AM; Stone GW
    J Am Coll Cardiol; 2009 May; 53(21):1965-72. PubMed ID: 19460609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    Ramanathan K; Abel JG; Park JE; Fung A; Mathew V; Taylor CM; Mancini GBJ; Gao M; Ding L; Verma S; Humphries KH; Farkouh ME
    J Am Coll Cardiol; 2017 Dec; 70(24):2995-3006. PubMed ID: 29241487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.